Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Stimulating the Resolution of Inflammation Through Omega-3 Polyunsaturated Fatty Acids in COVID-19: Rationale for the COVID-Omega-F Trial
Hildur Arnardottir, Sven‐Christian Pawelzik, Ulf Öhlund Wistbacka, et al.
Frontiers in Physiology (2021) Vol. 11
Open Access | Times Cited: 66

Showing 1-25 of 66 citing articles:

The roles of lipids in SARS-CoV-2 viral replication and the host immune response
Katherine N. Theken, Soon Yew Tang, Shaon Sengupta, et al.
Journal of Lipid Research (2021) Vol. 62, pp. 100129-100129
Open Access | Times Cited: 70
Dietary Supplements and Nutraceuticals under Investigation for COVID-19 Prevention and Treatment
Ronan Lordan, Halie M. Rando, Casey S. Greene
mSystems (2021) Vol. 6, Iss. 3
Open Access | Times Cited: 55
E-series resolvin metabolome, biosynthesis and critical role of stereochemistry of specialized pro-resolving mediators (SPMs) in inflammation-resolution: Preparing SPMs for long COVID-19, human clinical trials, and targeted precision nutrition
Charles N. Serhan, Stephania Libreros, Robert Nshimiyimana
Seminars in Immunology (2022) Vol. 59, pp. 101597-101597
Open Access | Times Cited: 51
Pneumonia-Induced Inflammation, Resolution and Cardiovascular Disease: Causes, Consequences and Clinical Opportunities
Cameron Stotts, Vicente F. Corrales–Medina, Katey J. Rayner
Circulation Research (2023) Vol. 132, Iss. 6, pp. 751-774
Closed Access | Times Cited: 23
Expert consensus report on lipid mediators: Role in resolution of inflammation and muscle preservation
Charles N. Serhan, Magnus Bäck, Valerio Chiurchiù, et al.
The FASEB Journal (2024) Vol. 38, Iss. 10
Open Access | Times Cited: 9
Plasma Linoleate Diols Are Potential Biomarkers for Severe COVID-19 Infections
Cindy B. McReynolds, Irene Cortés‐Puch, Resmi Ravindran, et al.
Frontiers in Physiology (2021) Vol. 12
Open Access | Times Cited: 51
Biological and Clinical Factors Contributing to the Metabolic Heterogeneity of Hospitalized Patients with and without COVID-19
Angelo D’Alessandro, Tiffany Thomas, Imo J. Akpan, et al.
Cells (2021) Vol. 10, Iss. 9, pp. 2293-2293
Open Access | Times Cited: 45
Investigating Lipid-Modulating Agents for Prevention or Treatment of COVID-19
Azita H. Talasaz, Parham Sadeghipour, Maryam Aghakouchakzadeh, et al.
Journal of the American College of Cardiology (2021) Vol. 78, Iss. 16, pp. 1635-1654
Open Access | Times Cited: 45
The effect of polyunsaturated fatty acids on the severity and mortality of COVID patients: A systematic review
Afrooz Mazidimoradi, Esmat Alemzadeh, Effat Alemzadeh, et al.
Life Sciences (2022) Vol. 299, pp. 120489-120489
Open Access | Times Cited: 30
pH influences the interfacial properties of blue whiting (M. poutassou) and whey protein hydrolysates determining the physical stability of fish oil-in-water emulsions
José María Ruiz-Álvarez, Teresa del Castillo-Santaella, Julia Maldonado‐Valderrama, et al.
Food Hydrocolloids (2021) Vol. 122, pp. 107075-107075
Open Access | Times Cited: 38
MS-based targeted profiling of oxylipins in COVID-19: A new insight into inflammation regulation
Denise Biagini, Maria Franzini, Paolo Oliveri, et al.
Free Radical Biology and Medicine (2022) Vol. 180, pp. 236-243
Open Access | Times Cited: 24
Immunomodulation by intravenous omega‐3 fatty acid treatment in older subjects hospitalized for COVID‐19: A single‐blind randomized controlled trial
Hildur Arnardottir, Sven‐Christian Pawelzik, Philip Sarajlic, et al.
Clinical and Translational Medicine (2022) Vol. 12, Iss. 9
Open Access | Times Cited: 24
Association between blood N-3 fatty acid levels and the risk of coronavirus disease 2019 in the UK Biobank
William S. Harris, Nathan Tintle, Swaminathan Perinkulam Sathyanarayanan, et al.
American Journal of Clinical Nutrition (2023) Vol. 117, Iss. 2, pp. 357-363
Open Access | Times Cited: 14
Effectiveness of Omega-3 Fatty Acid Supplementation in Improving the Metabolic and Inflammatory Profiles of Mexican Adults Hospitalized with COVID-19
Diana Rodríguez-Vera, Juan Rodrigo Salazar, Marvin A. Soriano‐Ursúa, et al.
Diseases (2024) Vol. 12, Iss. 1, pp. 28-28
Open Access | Times Cited: 4
Harnessing self-assembled nanoplatform of Dexamethasone and α-linolenic acid for high-efficiency inhibition of pulmonary cytokine storm and fibrosis in mice
Hongbing Liu, Muse Ji, Yi Qin, et al.
Nano Today (2024) Vol. 55, pp. 102201-102201
Closed Access | Times Cited: 4
Is Lipid Metabolism of Value in Cancer Research and Treatment? Part II: Role of Specialized Pro-Resolving Mediators in Inflammation, Infections, and Cancer
Muhammad Usman Babar, Ala F. Nassar, Xinxin Nie, et al.
Metabolites (2024) Vol. 14, Iss. 6, pp. 314-314
Open Access | Times Cited: 4
The role of omega-3 polyunsaturated fatty acids in the intensive care unit
Pierre Singer, Philip C. Calder
Current Opinion in Clinical Nutrition & Metabolic Care (2023) Vol. 26, Iss. 2, pp. 129-137
Open Access | Times Cited: 11
Mixed storm in SARS‐CoV‐2 infection: A narrative review and new term in the Covid‐19 era
Basil Mohammed Alomair, Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, et al.
Immunity Inflammation and Disease (2023) Vol. 11, Iss. 4
Open Access | Times Cited: 11
Targeted Application of Functional Foods as Immune Fitness Boosters in the Defense against Viral Infection
Dearbhla Finnegan, Restituto Tocmo, Christine E. Loscher
Nutrients (2023) Vol. 15, Iss. 15, pp. 3371-3371
Open Access | Times Cited: 10
Omega-3 Index and Clinical Outcomes of Severe COVID-19: Preliminary Results of a Cross-Sectional Study
Rodrigo Zapata B., José Miguel Müller, Juan Vásquez, et al.
International Journal of Environmental Research and Public Health (2021) Vol. 18, Iss. 15, pp. 7722-7722
Open Access | Times Cited: 24
Plasma Oxylipins and Their Precursors Are Strongly Associated with COVID-19 Severity and with Immune Response Markers
Naama Karu, Alida Kindt, Lieke Lamont, et al.
Metabolites (2022) Vol. 12, Iss. 7, pp. 619-619
Open Access | Times Cited: 17
Montelukast Inhibits Platelet Activation Induced by Plasma From COVID-19 Patients
Marina Camera, Paola Canzano, Marta Brambilla, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 16
Structural characterization ofPoria cocosoligosaccharides and their effects on the hepatic metabolome in high-fat diet-fed mice
Lin Zhu, Guangming Chen, Yanlei Guo, et al.
Food & Function (2022) Vol. 13, Iss. 12, pp. 6813-6829
Closed Access | Times Cited: 16
Multi-Omics Reveals Mechanisms of Partial Modulation of COVID-19 Dysregulation by Glucocorticoid Treatment
Matt Spick, A. Campbell, Ivona Baričević-Jones, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 20, pp. 12079-12079
Open Access | Times Cited: 16
Decreased oxidative stress and altered urinary oxylipidome by intravenous omega-3 fatty acid emulsion in a randomized controlled trial of older subjects hospitalized for COVID-19
Sven‐Christian Pawelzik, Hildur Arnardottir, Philip Sarajlic, et al.
Free Radical Biology and Medicine (2022) Vol. 194, pp. 308-315
Open Access | Times Cited: 16
Page 1 - Next Page

Scroll to top